Clinical characteristics & course of migraine headache in patients with epilepsy.

Recruiting

• Conditions: Migraine, unspecified; Epilepsy; G43.9; G40

• Registration Number: DRKS00029925
• Lead Sponsor: Klinikum Großhadern, LMU München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Patients with migraine (chronic or episodic) and epilepsy.
- Age = 18

Exclusion Criteria

- Secondary headache (tumor-related, traumatic brain injury)
- Age < 18
- Lack of ability to adequately describe the complaints
- Lack of written consent or lack of ability to give consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary: Analysis of the number of intensity & headache days per month during the course of epilepsies.<br><br>Duration of studies<br>The study duration is 5 years. Patients will be interviewed prospectively by telephone/at the scheduled follow-up about headache days, headache intensity, medication and other complaints. A standardized questionnaire is used for this purpose. The individual interview takes about 15 minutes.<br>

Secondary Outcome Measures

Name	Time	Method
Secondary: semiology of headache, course of headache with respect to established and newer anticonvulsant medications, seizure frequency, epilepsy syndrome.